Logotipo do repositório
 

Publicação:
OXFORD VACCINE AND TRANSFER OF TECHNOLOGY TO BRAZIL: POSSIBLE BENEFITS AMONG THE ADVERSITIES DUE THE COVID-19 PANDEMIC

dc.contributor.authorMenezes, Daniel Francisco Nagao [UNESP]
dc.contributor.authorDE MARTINI, Maria Carolina Gervásio Angelini
dc.contributor.authorPonchio, Milena Libralon Kosaki
dc.contributor.authorPereira, Roberta Battisti
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionCentro Universitário Toledo
dc.contributor.institutionUniversidade de Passo Fundo (UPF)
dc.date.accessioned2023-07-29T13:11:37Z
dc.date.available2023-07-29T13:11:37Z
dc.date.issued2023-01-01
dc.description.abstractObjective: to understand the concatenation of acts related to technological innovation in the face of the Covid-19 pandemic and its possible positive consequences for Brazil. Thus, the scenario resulting from the spread of the new coronavirus and vaccine development processes for its eradication will be analyzed, as well as the role of regulatory agencies, comparing pre-and post-pandemic procedures. Next, considerations will be brought about the ChAdOx1 nCoV-19 vaccine, the result of a partnership between the University of Oxford and the biopharmaceutical AstraZeneca, from the United Kingdom, with the Oswaldo Cruz Foundation, from Brazil, and the international technology transfer agreement signed between the institutions. Methodology: national and international data will be examined, as well as Brazilian regulations, collected from official electronic pages of health agencies and institutions responsible for developing the vaccine, in addition to using legal dogmatics, specifically doctrine, with a deductive approach. Results: it is observed that the acts practiced by the Brazilian parties appropriately considered the consequences of the decisions taken and advanced towards fulfilling their intrinsic value and achieving positive results for the country and its people, such as obtaining new technologies, future autonomy in production of vaccines and the resulting economic, social and public health gains from such achievements. Contributions: it should be noted that the work is original and contributes to mastering the transformations experienced worldwide, since, in the global search for a solution that can eradicate the disease, there has been a significant acceleration in national and international movements and cooperation, which are being of greater importance to contribute to the advancement of studies in order to stop the pandemic, also promoting human dignity and enabling social and economic development.en
dc.description.affiliationUNESP
dc.description.affiliationUNICAMP.
dc.description.affiliationCentro Universitário Toledo
dc.description.affiliationUniversidade de Passo Fundo (UPF)
dc.description.affiliationUnespUNESP
dc.format.extent291-323
dc.identifierhttp://dx.doi.org/10.26668/revistajur.2316-753X.v1i73.5041
dc.identifier.citationRevista Juridica, v. 1, n. 73, p. 291-323, 2023.
dc.identifier.doi10.26668/revistajur.2316-753X.v1i73.5041
dc.identifier.issn2316-753X
dc.identifier.scopus2-s2.0-85154532626
dc.identifier.urihttp://hdl.handle.net/11449/247278
dc.language.isopor
dc.relation.ispartofRevista Juridica
dc.sourceScopus
dc.subjectAstraZeneca
dc.subjectCovid-19
dc.subjectFiocruz
dc.subjectOxford
dc.subjecttechnology transfer
dc.subjectvaccine
dc.titleOXFORD VACCINE AND TRANSFER OF TECHNOLOGY TO BRAZIL: POSSIBLE BENEFITS AMONG THE ADVERSITIES DUE THE COVID-19 PANDEMICen
dc.titleVACINA DE OXFORD E TRANSFERÊNCIA DE TECNOLOGIA PARA O BRASIL: POSSÍVEIS BENEFÍCIOS EM MEIO ÀS ADVERSIDADES DECORRENTES DA PANDEMIA DE COVID-19pt
dc.typeArtigo
dspace.entity.typePublication

Arquivos

Coleções